These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Effectiveness of single- vs dual-coil implantable defibrillator leads: An observational analysis from the SIMPLE study. Neuzner J; Hohnloser SH; Kutyifa V; Glikson M; Dietze T; Mabo P; Vinolas X; Kautzner J; O'Hara G; Lawo T; Brachmann J; VanErven L; Gadler F; Appl U; Wang J; Connolly SJ; Healey JS J Cardiovasc Electrophysiol; 2019 Jul; 30(7):1078-1085. PubMed ID: 30945798 [TBL] [Abstract][Full Text] [Related]
44. Sudden cardiac death in dialysis patients: different causes and management strategies. Genovesi S; Boriani G; Covic A; Vernooij RWM; Combe C; Burlacu A; Davenport A; Kanbay M; Kirmizis D; Schneditz D; van der Sande F; Basile C; Nephrol Dial Transplant; 2021 Feb; 36(3):396-405. PubMed ID: 31538192 [TBL] [Abstract][Full Text] [Related]
45. Will imaging assist in the selection of patients with heart failure for an ICD? Gerson MC; Abdallah M; Muth JN; Costea AI JACC Cardiovasc Imaging; 2010 Jan; 3(1):101-10. PubMed ID: 20129539 [TBL] [Abstract][Full Text] [Related]
46. Can QRS scoring predict left ventricular scar and clinical outcomes? Rosengarten JA; Scott PA; Chiu OK; Shambrook JS; Curzen NP; Morgan JM Europace; 2013 Jul; 15(7):1034-41. PubMed ID: 23493411 [TBL] [Abstract][Full Text] [Related]
47. Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement. Mithani AA; Kath H; Hunter K; Andriulli J; Ortman M; Field J; Russo AM Europace; 2018 Feb; 20(2):308-314. PubMed ID: 28383717 [TBL] [Abstract][Full Text] [Related]
48. Implantable cardioverter-defibrillator lead failure: how weak is the link? Brinker JA Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965 [TBL] [Abstract][Full Text] [Related]
49. The implantable cardioverter-defibrillator: An update. Miller JD; Yousuf O; Berger RD Trends Cardiovasc Med; 2015 Oct; 25(7):606-11. PubMed ID: 25912255 [TBL] [Abstract][Full Text] [Related]
50. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials. Moss AJ Cardiol J; 2013; 20(3):217-9. PubMed ID: 23788293 [No Abstract] [Full Text] [Related]
51. The Occurrence of Implantable Cardioverter Defibrillator Therapies After Generator Replacement in Patients Who No Longer Meet Primary Prevention Indications. Kawata H; Hirai T; Doukas D; Hirai R; Steinbrunner J; Wilson J; Noda T; Hsu J; Krummen D; Feld G; Wilber D; Santucci P; Birgersdotter-Green U J Cardiovasc Electrophysiol; 2016 Jun; 27(6):724-9. PubMed ID: 26915696 [TBL] [Abstract][Full Text] [Related]
52. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death. Au-Yeung WT; Reinhall PG; Poole JE; Anderson J; Johnson G; Fletcher RD; Moore HJ; Mark DB; Lee KL; Bardy GH Heart Rhythm; 2015 Oct; 12(10):2058-66. PubMed ID: 26096609 [TBL] [Abstract][Full Text] [Related]
53. Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Robin J; Weinberg K; Tiongson J; Carnethon M; Reddy M; Ciaccio C; Quadrini M; Hsu J; Fan J; Choi P; Kadish A; Goldberger J; Passman R Heart Rhythm; 2006 Oct; 3(10):1196-201. PubMed ID: 17018351 [TBL] [Abstract][Full Text] [Related]
54. Arrhythmic outcome of arrhythmogenic right ventricular cardiomyopathy patients without implantable defibrillators. Wang W; Cadrin-Tourigny J; Bhonsale A; Tichnell C; Murray B; Monfredi O; Chrispin J; Crosson J; Tandri H; James CA; Calkins H J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1396-1402. PubMed ID: 29894017 [TBL] [Abstract][Full Text] [Related]
55. Risk assessment for sudden cardiac death in dialysis patients: how relevant are conventional cardiac risk factors? Saravanan P; Freeman G; Davidson NC Int J Cardiol; 2010 Oct; 144(3):431-2. PubMed ID: 19344968 [TBL] [Abstract][Full Text] [Related]
56. The subcutaneous implantable cardioverter-defibrillator: A tertiary center experience. Khazen C; Magnusson P; Flandorfer J; Schukro C Cardiol J; 2019; 26(5):543-549. PubMed ID: 29718532 [TBL] [Abstract][Full Text] [Related]